AR and neoplasm: In patients with ER-positive tumors, multivariate analysis revealed that AR(-)/FOXA1(-) tumors were independently poor prognostic factors for DFS and OS when age at diagnosis, tumor and node stage, histologic grade, HER2, Ki-67, and use of chemotherapy and endocrine therapy were adjusted (Table 2).